|
GNL3L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54274999999426E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.203100E-04 |
| Normal-vs-Stage2 |
3.233400E-04 |
| Normal-vs-Stage3 |
1.59728999999942E-05 |
| Normal-vs-Stage4 |
1.62979999995816E-06 |
| Stage1-vs-Stage2 |
2.306800E-01 |
| Stage1-vs-Stage3 |
4.877600E-02 |
| Stage1-vs-Stage4 |
1.929700E-02 |
| Stage2-vs-Stage3 |
6.646200E-01 |
| Stage2-vs-Stage4 |
4.945800E-01 |
| Stage3-vs-Stage4 |
8.281200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.02329999999806E-05 |
| Normal-vs-AfricanAmerican |
1.26310000003738E-06 |
| Normal-vs-Asian |
5.022800E-01 |
| Caucasian-vs-AfricanAmerican |
9.777700E-02 |
| Caucasian-vs-Asian |
3.229800E-02 |
| AfricanAmerican-vs-Asian |
4.400100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.32039999999989E-05 |
| Normal-vs-Female |
3.67199999999901E-05 |
| Male-vs-Female |
5.402600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.372200E-04 |
| Normal-vs-Age(41-60Yrs) |
1.643320E-03 |
| Normal-vs-Age(61-80Yrs) |
4.0816000002053E-07 |
| Normal-vs-Age(81-100Yrs) |
1.359380E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.880040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.429800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.605000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.760500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.392600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.142600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.440000E-01 |
| Normal-vs-Grade 2 |
1.036000E-04 |
| Normal-vs-Grade 3 |
5.87639999999334E-05 |
| Normal-vs-Grade 4 |
4.31720000004798E-06 |
| Grade 1-vs-Grade 2 |
8.631700E-02 |
| Grade 1-vs-Grade 3 |
7.314400E-02 |
| Grade 1-vs-Grade 4 |
2.100100E-02 |
| Grade 2-vs-Grade 3 |
4.122200E-01 |
| Grade 2-vs-Grade 4 |
7.455600E-02 |
| Grade 3-vs-Grade 4 |
2.941800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.136700E-03 |
| Normal-vs-ccB subtype |
6.22000000000122E-05 |
| ccA subtype-vs-ccB subtype |
6.442100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.439700E-04 |
| Normal-vs-N1 |
1.510440E-02 |
| N0-vs-N1 |
6.424800E-01 |
|
|
